This inventor holds 3 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignees: Mcgill University, Institut National De Recherche Pour L'agriculture, L'alimentation Et L'environnement, National Institute for Agricultural Research. Active years: 2014-2021.
Location History:
- Ste-Anne-de-Bellevue, CA (2014)
- Toulouse, FR (2021)
Company Filing History:
3 out of 570 
1 out of 49 
1 out of 285 
Years Active: 2014-2021
Title: Roger Prichard: Innovator in Parasitic Infection Treatment
Introduction
Roger Prichard is a notable inventor based in Toulouse, France. He has made significant contributions to the field of parasitology through his innovative research and inventions. With a total of 3 patents, Prichard has focused on enhancing the efficacy of treatments for parasitic infections.
Latest Patents
Prichard's latest patents include the use of avermectin derivatives to increase the bioavailability and efficacy of macrocyclic lactones. This invention relates to the application of avermectin derivatives as drugs for treating parasitic infections. The specific formula involves various components, including groups such as cyclohexyl and hydroxyl, which play crucial roles in inhibiting membrane-bound proteins that transport exogenous compounds out of target cells.
Career Highlights
Throughout his career, Roger Prichard has worked with esteemed institutions such as the Royal Institution for the Advancement of Learning / McGill University and the Institut National de Recherche Pour L'Agriculture, L'Alimentation Et L'Environnement. His work has significantly advanced the understanding and treatment of parasitic diseases.
Collaborations
Prichard has collaborated with notable colleagues, including Anne Lespine and Cecile Menez. Their joint efforts have contributed to the development of innovative solutions in the field of parasitology.
Conclusion
Roger Prichard's contributions to the treatment of parasitic infections through his innovative patents highlight his role as a leading inventor in this critical area of research. His work continues to influence the development of effective therapies for parasitic diseases.